Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Volatolomic and Proteomic Profile; Breath, Urine and Serum as Non-invasive Tools for Early Diagnosis of Lung Cancer

NCT06341387 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06341387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06341387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Volatolomic and Proteomic Profile; Breath, Urine and Serum as Non-invasive Tools for Early Diagnosis of Lung Cancer
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Unknown status
Start date
May 5, 2023
Completion date
July 31, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer diagnosis, non-small cell lung cancer stage i, non-small cell lung cancer stage ii